Mitoxantrone

Chemical formula: C₂₂H₂₈N₄O₆  Molecular mass: 444.481 g/mol  PubChem compound: 4212

Therapeutic indications

Mitoxantrone is indicated for:

Multiple sclerosis

Population group: only adults (18 years old or older)

Mitoxantrone is indicated for treatment of patients with highly active relapsing multiple sclerosis associated with rapidly evolving disability where no alternative therapeutic options exist.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Metastatic breast cancer

Population group: only adults (18 years old or older)

Mitoxantrone is indicated in the treatment of metastatic breast cancer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Non-Hodgkin's lymphoma

Population group: only adults (18 years old or older)

Mitoxantrone is indicated in the treatment of non-Hodgkin’s lymphoma.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acute myeloid leukaemia (AML)

Population group: only adults (18 - 65 years old)

Mitoxantrone is indicated for the treatment of acute myeloid leukaemia (AML) in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Blast crisis in chronic myeloid leukaemia

Population group: only adults (18 years old or older)

Mitoxantrone in combination regimens is indicated in the remission-induction treatment of blast crisis in chronic myeloid leukaemia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Advanced castrate resistant prostate cancer

Population group: men, only adults (18 years old or older)

Mitoxantrone is indicated in combination with corticosteroids for palliation (e.g. pain relief) related to advanced castrate resistant prostate cancer.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Mitoxantrone is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.